文献速递乳腺US乳腺X线

超声作为哺乳期女性可触及乳腺肿块首选影像检查方法,包括高龄产妇

US as the Primary Imaging Modality in the Evaluation of Palpable Breast Masses in Breastfeeding Women, Including Those of Advanced Maternal Age.
PubMed 文献 · Radiology · 2020-09-01

该回顾性研究纳入17年间167例哺乳期可触及乳腺肿块女性(平均35岁±5,60%为高龄产妇≥35岁),评估靶向超声作为首选影像方法的诊断效能。靶向超声检出全部5例恶性肿瘤,敏感度100%、特异度70%;98例加做乳腺X线后仅增加7个可疑 incidental 发现,特异度从67%降至61%(P=0.02),未增加任何癌症诊断。

要点

  • 哺乳期可触及乳腺肿块行靶向超声,敏感度100%(5/5),阴性预测值100%(114/114)。
  • 超声异常者阳性预测值仅9.4%(5/53),活检阳性预测值10%(5/50)。
  • 加做乳腺X线使特异度从67%(62/93)降至61%(57/93)(P=0.02),未增加癌症诊断。

核心结论

  • 靶向超声检出哺乳期可触及乳腺肿块女性的全部恶性肿瘤。
  • 加做乳腺X线增加假阳性发现,未增加任何癌症诊断。

研究设计与样本

  • 回顾性识别2000年1月至2017年7月共17年间因可触及乳腺肿块行靶向超声评估的哺乳期女性。
  • 共167例女性,平均年龄35岁±5(标准差),其中101例(60%)为高龄产妇(≥35岁)。
  • 所有超声评估均在诊断评估时进行,乳腺X线由判读放射科医师酌情决定,98例(59%)加做乳腺X线。
  • 收集乳腺影像报告和数据系统评估、影像及病理结果,在患者层面进行描述性统计和2×2列联表分析。

诊断标准与关键数值

  • 靶向超声诊断恶性:敏感度5/5(100%;95%CI:48%,100%),特异度114/162(70%;95%CI:63%,77%)。
  • 阴性预测值114/114(100%;95%CI:97%,100%),超声异常阳性预测值5/53(9.4%;95%CI:3%,21%),活检阳性预测值5/50(10%;95%CI:3%,22%)。
  • 恶性频率5/167(3.0%)。
  • 在98例同时行超声和乳腺X线的女性中,乳腺X线显示7个 incidental 可疑发现,特异度从62/93(67%;95%CI:56%,76%)降至57/93(61%;95%CI:51%,71%)(P=0.02)。

临床应用与阅片要点

  • 对哺乳期可触及乳腺肿块女性,靶向超声可作为首选影像方法评估。
  • 哺乳期女性加做乳腺X线可能增加假阳性发现而不增加癌症诊断,需结合临床酌情决定。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Women are increasingly delaying childbearing, and thus lactation, into their 30s and 40s, when mammography would typically be the initial imaging modality to evaluate palpable masses in the general population. Current guidelines recommend US as the first-line imaging modality for palpable masses in pregnant and lactating women, but data regarding breastfeeding women age 30 years and older are near nonexistent. Purpose To evaluate the diagnostic performance of targeted US as the primary imaging modality for the evaluation of palpable masses in lactating women, including those of advanced maternal age. Materials and Methods Lactating women with palpable breast masses evaluated at targeted US over a 17-year period (January 2000 to July 2017) were retrospectively identified. All US evaluations were performed at diagnostic evaluation, and mammography was performed at the discretion of the interpreting radiologist. Breast Imaging Reporting and Data System assessments, imaging, and pathology results were collected. Descriptive statistics and 2 × 2 contingency tables were assessed at the patient level. Results There were 167 women (mean age, 35 years ± 5 [standard deviation]), 101 of whom (60%) were of advanced maternal age (≥35 years). All women underwent targeted US, and 98 (59%) underwent mammography in addition to US. The frequency of malignancy was five of 167 (3.0%). Targeted US demonstrated a sensitivity and specificity of five of five (100%; 95% confidence interval [CI]: 48%, 100%) and 114 of 162 (70%; 95% CI: 63%, 77%), respectively. Negative predictive value, positive predictive value of an abnormal examination, and positive predictive value of biopsy were 114 of 114 (100%; 95% CI: 97%, 100%), five of 53 (9.4%; 95% CI: 3%, 21%), and five of 50 (10%; 95% CI: 3%, 22%), respectively. In the subset of 98 women who underwent mammography in addition to US, mammography depicted seven incidental suspicious findings, which lowered the specificity from 62 of 93 (67%; 95% CI: 56%, 76%) to 57 of 93 (61%; 95% CI: 51%, 71%) (P = .02). Conclusion Targeted US depicted all malignancies in lactating women with palpable masses. Adding mammography increased false-positive findings without any additional cancer diagnoses. © RSNA, 2020 See also the editorial by Newell in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Chung M, Hayward JH, Woodard GA, et al. US as the Primary Imaging Modality in the Evaluation of Palpable Breast Masses in Breastfeeding Women, Including Those of Advanced Maternal Age. Radiology. 2020. PMID: 32870133. doi:10.1148/radiol.2020201036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。